Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02040714Enrolling By Invitation

Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

Role: collaborator

NCT04469335Not ApplicableUnknown

Effectiveness of a Mobile Neurofeedback for ADHD Youth

Role: lead

NCT02670876Not ApplicableCompleted

Effectiveness of an Anti-bullying Intervention for Adolescent Perpetrators

Role: lead

NCT02623114Phase 4Unknown

Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers

Role: lead

NCT01716442Phase 2Unknown

Rituximab Trial for Pediatric Nephrotic Syndrome

Role: lead

All 5 trials loaded